Ling-Chun Chen
Overview
Explore the profile of Ling-Chun Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1434
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chu C, Cheng W, Wen B, Liang Y, Sheu M, Chen L, et al.
Gels
. 2024 Dec;
10(12).
PMID: 39727534
This study presents the development of thiol-maleimide/thiol-thiol double self-crosslinking hyaluronic acid-based (HA) hydrogels for use as dermal fillers. Hyaluronic acid with varying degrees of maleimide substitution (10%, 20%, and 30%)...
2.
Sidoli M, Chen L, Lu A, Wandless T, Talbot W
ACS Chem Biol
. 2024 Mar;
19(4):1022.
PMID: 38456802
No abstract available.
3.
Lin C, Cheng W, Chen L, Chen T, Sheu M, Lin H
Int J Pharm
. 2023 Sep;
645:123370.
PMID: 37666310
This study aimed to evaluate gemcitabine (GEM)/paclitaxel (PTX) co-loaded into a lecithin-based self-nanoemulsifying preconcentrate (SNEP) orally administered in a metronomic therapeutic manner against pancreatic cancer. SNEP was developed and evaluated,...
4.
Lin C, Lin H, You W, Ho H, Sheu M, Chen L, et al.
J Funct Biomater
. 2023 Aug;
14(8).
PMID: 37623667
In this study, an ultrasound-assisted digestion method of a formic acid-decellularized extracellular matrix (dECM) of porcine skin was developed and optimized to form UdECM hydrogels for diabetic wound healing. Results...
5.
Liang Y, Cheng W, Chen L, Sheu M, Lin H
Pharmaceutics
. 2023 May;
15(5).
PMID: 37242670
Sangelose (SGL) is a novel hydroxypropyl methylcellulose (HPMC) derivative that has been hydrophobically modified. Due to its high viscosity, SGL has the potential as a gel-forming and release-rate-controlled material for...
6.
Liu Y, Chen L, Cheng W, Wei P, Hsieh C, Sheu M, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839795
In recent years, combining different types of therapy has emerged as an advanced strategy for cancer treatment. In these combination therapies, oral delivery of anticancer drugs is more convenient and...
7.
Chen L, Lin S, Cheng W, Sheu M, Chung C, Hsu C, et al.
Drug Deliv
. 2023 Jan;
30(1):2158964.
PMID: 36587631
The purpose of this study was to develop poloxamer (P407)-based in-situ thermogellable hydrogels with reducing concentration of P407 by adding hypromellose (HPMC) and with enhancing mucoadhesion of resulting hydrogels by...
8.
Cheng W, Lin S, Chuang K, Chen M, Ho H, Chen L, et al.
Int J Nanomedicine
. 2022 Nov;
17:5353-5374.
PMID: 36419719
Introduction: Approximately 15%~30% of breast cancers have gene amplification or overexpression of the human epidermal growth factor receptor 2 (HER2), resulting in the chemotherapy resistance, a more-aggressive phenotype and poor...
9.
Sidoli M, Chen L, Lu A, Wandless T, Talbot W
ACS Chem Biol
. 2022 Jul;
17(8):2024-2030.
PMID: 35839076
cAMP is a ubiquitous second messenger with many functions in diverse organisms. Current cAMP sensors, including Föster resonance energy transfer (FRET)-based and single-wavelength-based sensors, allow for real time visualization of...
10.
Hsu H, Cheng C, Shiu J, Chen L, Chen Y
Opt Express
. 2022 Feb;
30(2):2097-2111.
PMID: 35209357
We present a full quantum model to study the fidelity of single photons with different quantum states propagating in a medium exhibiting electromagnetically induced transparency (EIT). By using the general...